Literature DB >> 6288969

Antibody to hepatitis A virus in healthy Nigerians.

E A Ayoola.   

Abstract

Two hundred and fifty Nigerians (175 male and 75 female), whose ages ranged from 5 to 70 years, were surveyed for the presence of antibody to hepatitis A virus (anti-HAV). The prevalence was determined to be 82 percent. The rates were highest in blood donors (90 percent) and hospital workers (91.4 percent) and lowest in children under the age of 10 (25 percent). The prevalence rates were not related to socioeconomic groups, previous exposure, jaundice, or sex. The study confirms that HAV infection is endemic in Nigeria and that most infections are subclinical and occur early in life. Acute hepatitis in a Nigerian adult may therefore not be due to HAV.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6288969      PMCID： PMC2552756     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  7 in total

1.  The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study.

Authors:  W Szmuness; J L Dienstag; R H Purcell; C E Stevens; D C Wong; H Ikram; S Bar-Shany; R P Beasley; J Desmyter; J A Gaon
Journal:  Am J Epidemiol       Date:  1977-11       Impact factor: 4.897

2.  Anti-hepatitis-A antibody in Spain.

Authors:  V Vargas; R Esteban; J D Pedreira; J Viladoms; J M Hernandez; J Guardia
Journal:  Lancet       Date:  1978-09-09       Impact factor: 79.321

3.  Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination.

Authors:  Y Moritsugu; J L Dienstag; J Valdesuso; D C Wong; J Wagner; J A Routenberg; R H Purcell
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody.

Authors:  R H Purcell; D C Wong; Y Moritsugu; J L Dienstag; J A Routenberg; J D Boggs
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

5.  Distribution of antibody to hepatitis a antigen in urban adult populations.

Authors:  W Szmuness; J L Dienstag; R H Purcell; E J Harley; C E Stevens; D C Wong
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

6.  Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.

Authors:  G G Frösner; G Papaevangelou; R Bütler; S Iwarson; A Lindholm; A Couroucé-Pauty; H Haas; F Deinhardt
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

7.  Antibody to hepatitis A antigen in institutionalized mentally retarded patients.

Authors:  W Szmuness; R H Purcell; J L Dienstag; C E Stevens
Journal:  JAMA       Date:  1977-04-18       Impact factor: 56.272
  7 in total
  3 in total

1.  Seroprevalence and predictors of hepatitis A infection in Nigerian children.

Authors:  Joanah Moses Ikobah; Henry Chima Okpara; Emmanuel Eyo Ekanem; Jacob Jackson Udo
Journal:  Pan Afr Med J       Date:  2015-02-12

2.  Hepatitis A virus in West Africa: Is an epidemiological transition beginning?

Authors:  Kathryn H Jacobsen
Journal:  Niger Med J       Date:  2014-07

3.  Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis.

Authors:  Christopher Ko Williams; Letizia Foroni; Lucio Luzzatto; Idris Saliu; Arthur Levine; Mel F Greaves
Journal:  Ecancermedicalscience       Date:  2014-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.